DSP and gastric cancer: Additionally, it has been confirmed through research that MIR4435-2HG has the ability to activate the Wnt/β-catenin signaling pathway by suppressing the expression of desmoplakin (DSP), thus promoting the growth and metastasis of gastric cancer [12].